j-n-p
18 Jan 2018
Re: up today RNS out today but they have the wrong date on it so click on the latest and you will see it.
tikky
18 Jan 2018
up today note up today any one know why i got in second time 163 few weeks backany news appriciated
Ripley94
02 Jan 2018
Re: 135p now, bigger wow Sliced 1/2 of what i have left @ 187pMarksman buying on Acta bb
oldjoe1
27 Dec 2017
IMM TIPPED........ IMM article on Motely Fool:[link]
senn1965
26 Dec 2017
Motif. Bio Mirror this soon?
Didledum
21 Dec 2017
ImmuPharma I am very happy to have bought and held a substantial number of these shares since early 2016 at an average price of less than 100p. The latest news from the company about Lukozor is good. You can make money here as a dealer, but for me this was and still is agamble on Lukozor.
oldjoe1
14 Dec 2017
Re: rise IMM Immupharma....... a look at the' feet on the ground'[link]
Nice to Michu
13 Dec 2017
Re: rise Th only thing I can say to that old Joe: is please can I have the 12,000 shares I've sold between 80 p and 160p back.. I've only 3000 left to sell now.. yikes..The market cap you're talk about off the back of the future s/p target numbers you quote is incredible to me .. especially, are you sutre about 877p ? (It's now the guts of a quarter of a billion mc.. that factorial is a big big big number indeed...)
oldjoe1
13 Dec 2017
Re: rise Finntech's 237p target for IMM Immupharma is 'at today'.They are also saying for successful Phase III trial results this would be increased 87% to 441p with Lupiznor revenue on top being 50p one-off and 386p recurring - so 877p.Phase III results due Q1
oldjoe1
12 Dec 2017
Re: rise <b>ImmuPharma PLC 40.2% Potential Upside Indicated by finnCapPosted by: Amilia Stone 12th December 2017</b>ImmuPharma PLC using EPIC/TICKER code (LON:IMM) a pharmaceutical company focusing on developing novel medicines with high sales potential has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘BUY’ this morning by analysts at finnCap. ImmuPharma PLC are listed in the Health Care sector within AIM. finnCap have set a target price of 237 GBX on its stock. This indicates the analyst now believes there is a potential upside of 40.2% from the opening price of 169 GBX. Over the last 30 and 90 trading days the company share price has increased 71 points and increased 121.75 points respectively. The 52 week high for the stock is 171.75 GBX while the 52 week low for the stock is 36 GBX.ImmuPharma PLC has a 50 day moving average of 105.55 GBX and a 200 Day Moving Average share price is recorded at . There are currently 129,665,818 shares in issue with the average daily volume traded being 360,049. Market capitalisation for LON:IMM is £222,340,888 GBP.
oldjoe1
12 Dec 2017
Re: IMM, Another broker Now Promotes It.... Finntech's 237p target for IMM is 'at today'.They are also saying for successful Phase III trial results this would be increased 87% to 441p with Lupiznor revenue on top being 50p one-off and 386p recurring - so 877p.Phase III results due Q1 😀😎
oldjoe1
12 Dec 2017
IMM, Another broker Now Promotes It.... IMM ImmuPharma starting to look hot again after broker FinnCap Initiated a start SP target of 237.00p on the stock. <img src="[link]
DIE HARD 1
11 Dec 2017
rise Nice rise today
Ripley94
08 Dec 2017
Re: 135p now, bigger wow Sold that buy back for 147p.Needed some funds for elsewhere.
Ripley94
28 Nov 2017
Re: 135p now, bigger wow Decided to correct that mistake and bought them back for 125p.Very volatile made a little .
